GlucoTrack, Inc. (NASDAQ: GCTK) shares surged 113.86% in post-market trading on Monday, climbing from a regular-session close of $2.02 to a last price of $4.32. The healthcare stock saw an extraordinary volume of 22.6 million shares change hands during the after-hours session, compared to its average daily volume of roughly 208,000 shares.

What We Know About the Move

The post-market spike follows a series of recent SEC filings that investors appear to be reacting to. The most recent 8-K was filed on September 18, 2026, at 9:10 PM ET. Three additional 8-Ks were filed during the week of September 11, including one tied to the company's $11.5 million financing announcement. The specific content of these filings has not been independently verified in this session, and the exact catalyst driving the after-hours move is not immediately clear from available sources.

Company Background

GlucoTrack, headquartered in Or Yehuda, Israel, is a medical technology company that developed a non-invasive glucose monitoring system for individuals with diabetes or pre-diabetes. The company, originally founded in 2001 as Integrity Applications, Inc., rebranded to GlucoTrack in November 2021.

The company completed a strategic business combination with Lōkahi Therapeutics in July 2026, establishing a Lōkahi-controlled public platform. E.F. Hutton & Co. served as the exclusive financial advisor and placement agent for approximately $5.7 million in convertible note financing tied to that combination. In August 2026, GlucoTrack achieved a key compliance milestone and advanced its strategic transformation, according to a Business Wire release.

Recent Financing Activity

On September 11, 2026, GlucoTrack announced an $11.5 million financing. That same day, the company filed an 8-K with the Securities and Exchange Commission. Additional filings followed on September 9, 14, and 18. The volume of recent regulatory activity, combined with the substantial financing raised over the past several months, reflects an active period for the small-cap company.

Why the Stock May Be Moving

Post-market moves of this magnitude in small-cap stocks often reflect a handful of dynamic factors:

  • A specific announcement or regulatory filing not immediately captured by news wires
  • Short-covering activity following a period of losses
  • Speculative trading around thinly traded stocks with limited float
  • Options or derivative-related hedging activity

GlucoTrack carries a float of approximately 565,000 shares and a market capitalization near $2.4 million, making it a low-float, micro-cap name. Such stocks are particularly prone to sharp price swings when volume spikes, as there are fewer shares available to absorb buying or selling pressure.

Looking Ahead

Traders should monitor for any additional filings or announcements from GlucoTrack following the September 18 8-K. Given the company's ongoing strategic transformation and recent capital raises, there may be further developments in the near term that could explain the move or provide context for continued volatility.

As always, extreme caution is warranted when trading stocks experiencing outsized after-hours moves with limited publicly available information.